This site requires JavaScript to be enabled to work properly. Please modify your settings or use a different browser to continue

You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.


Go back

Optimising the Paediatric Severe Asthma Journey

Optimising the Paediatric Severe Asthma Journey


Four severe asthma experts discuss key aspects of the paediatric severe asthma journey. Topics covered include who, when and why to refer to a paediatric severe asthma service, the adolescent homecare service, and transitioning from adolescent to adult service.


Dr Deb Marriage headshot

Dr Deb Marriage

Consultant Nurse for Paediatric Allergy & Asthma, The Bristol Royal Hospital for Children

Deb Marriage is the Consultant Nurse for Asthma & Allergy at Bristol Royal Hospital for Children where she has worked since the allergy service began in 2002. She previously worked in allergy at St Mary’s Hospital, London. Deb has completed the MSc in Allergy at Southampton University and a Professional Doctorate in Health at the University of Bath.

She is Secretary of the British Society of Allergy and Clinical Immunology and is an advocate for nurse-led services and in promoting the extended role of nurses. She enjoys research and her particular interests are in asthma, and in egg and nut allergies. Her current project focuses on improving joint working in asthma with Primary care.

Headshot of Angela Jamalzadeh

Angela Jamalzadeh

Children's Respiratory Nurse Specialist, The Royal Brompton, London

Angela undertook her nurse training at University of Hertfordshire and qualified in 2008. She worked as a staff nurse and then as a junior sister on a general paediatric ward before taking on the role of Paediatric specialist asthma nurse in West London in 2013. Angela has been at the Royal Brompton Hospital since 2014 in the role of Paediatric Clinical Nurse Specialist in Respiratory care, working as part of the Paediatric Difficult Asthma Team, and has completed her MsC Allergy from Imperial College London.

Dr Prasad Nagakumar headshot

Dr Prasad Nagakumar

Paediatric Respiratory Consultant, Birmingham Children's Hospital

Prasad is a paediatric respiratory consultant at Birmingham Children’s Hospital (BCH) and a Honorary Senior Lecturer at the University of Birmingham. He leads the severe asthma service at BCH and coordinates the West Midlands paediatric severe asthma network. He is the only paediatrician in the Birmingham Regional Adult Severe Asthma Service and has set up transition and research links with Prof Adel Mansur.

Prasad’s research interests include understanding the pathophysiology of children with severe asthma, evaluation of invasive/non invasive biomarkers in childhood asthma, adherence monitoring and use of novel approached in management of asthma. He is the chief investigator for MUCOSA study (Mucus Hypersecretion in Children with severe Asthma), CHAMP (Childhood Home Asthma Monitoring Study) an NIHR-AI funded project.

Dr Pujan Patel headshot

Dr Pujan Patel

Respiratory Consultant, The Royal Brompton, London

Dr Pujan Patel is a Consultant in Respiratory Medicine with expertise in Severe Asthma management at the Royal Brompton Hospital. Having completed fellowships in both Respiratory and Critical Care Medicine in the United States, he joined the Brompton’s Severe Asthma service in managing the UK’s largest cohort of severe asthmatics on asthma biologic therapies. He is responsible for the assessment of new tertiary referrals to the service and conducts weekly biologic MDTs to identify suitable biologic candidates. He serves on various subgroup committees for the British Thoracic Society (BTS) and American Thoracic Society (ATS) and continues to engage in medical education and teaching.

If you would like to contact one of our account managers, please fill in this form.

Adverse events should be reported. Reporting forms and information can be found at or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on +44 (0)800 221 441